CAS: 39232-04-7; 2-(2-Bromoethyl)Pyridine

该化合物是一种有机化合物,其特征为:环,是含有一个氮原子的由六人组成的芳香热循环,含有一个氮原子;该化合物的特征是附于环第二个碳的溴乙基组,使其成为替代的衍生物;它一般是一种无色的黄色液体或固态,视其纯度和形态而定;溴原子的存在具有重大的再活动性,特别是在核生殖替代反应方面,使其在各种合成应用中有用,包括制作更复杂的有机分子;该化合物在有机溶剂中溶解,并由于电阴性氮和溴原子的特性而表现出中度极性;其化学特性包括能够进行电解芳香替代并参与典型的烷基卤化物反应;在处理该化合物时,应当采取安全防范措施,因为其溴含量和潜在毒性可能对健康造成危害.

结构式图片

相似化合物

72996-65-7 16927-00-7 856834-88-3

欧盟法规

C&L通报

上下游产品

2-羟乙基吡啶 2-(2-Hydroxyethyl)Pyridine 103-74-2

合成工艺路线路线简述

    📜2-(2-溴乙基)吡啶氢溴酸盐置于sodium Hydroxide体系中,用95%的收率获得2-(2-溴乙基)吡啶
    参考文献:Spiro Derivatives Of Tetrahydrothiophene. Synthesis Of The Quinolizidine <3-Spiro-2'> Tetrahydrothiophene System Using Solid/liquid Or Liquid/liquid Phase-Transfer Catalysis
    标题:Spiro Derivatives Of Tetrahydrothiophene. Synthesis Of The Quinolizidine <3-Spiro-2'> Tetrahydrothiophene System Using Solid/liquid Or Liquid/liquid Phase-Transfer Catalysis
    摘要:4-氧代八氢喹啉<3-螺-2'>四氢噻吩1',1'-二氧化物可以通过两条独立的途径从2-氰基四氢噻吩合成,两者均使用相转移催化:第一条途径涉及在ptc条件下对2-氰基四氢噻吩进行烷基化,第二条途径则是使用2-氯乙基哌啶与2-氯羰基四氢噻吩进行n-酰化,最后在ptc条件下进行环烷基化.得到两个螺旋化合物的立体异构体.
    Doi:10.1055/s-1987-33430

    海关参考信息

    专利信息


    专利号:US-7692019-B2
    优先权日:2000-12-04
    标 题:Methods for the stereoselective synthesis of substituted piperidines
    发明人:AQUILA BRIAN M; BANNISTER THOMAS D; CUNY GREGORY D; HAUSKE JAMES R; HEFFERNAN MICHELE L R; HOEMANN MICHAEL Z; KESSLER DONALD W; SHAO LIMING; WU XINHE; XIE ROGER L
    权利人:SEPRACOR INC
    摘要:One aspect of the present invention relates to methods of synthesizing substituted piperidines. A second aspect of the present invention relates to stereoselective methods of synthesizing substituted piperidines. The methods of the present invention will find use in the synthesis of compounds useful for treatment of numerous ailments, conditions and diseases that afflict mammals, including but not limited to addiction and pain. An additional aspect of the present invention relates to the synthesis of combinatorial libraries of the substituted piperidines using the methods of the present invention. An additional aspect of the present invention relates to enantiomerically substituted pyrrolidines, piperidines, and azepines.

    专利号:US-2025129021-A1
    优先权日:2023-09-19
    标 题:Small molecule protein synthesis modulators
    发明人:GYGI DAVID; BAHMANYAR SOGOLE SAMI; HAMANN LAWRENCE
    权利人:INTERDICT BIO INC
    摘要:The present disclosure provides compounds of the formulae herein (e.g., Formula (I), Formula (V)), and pharmaceutically acceptable salts thereof, which are useful for modulating protein synthesis (e.g., modulating synthesis of BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D). The present disclosure also provides pharmaceutical compositions and kits comprising the compounds, or pharmaceutically acceptable salts thereof, and methods of treating or preventing diseases or disorders (e.g., diseases or disorders associated with BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D) by administering to a subject in need thereof the compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof.

    专利号:US-4486572-A
    优先权日:1983-07-06
    标 题 :Synthesis of amphiphilic block copolymers and networks
    发明人:KENNEDY JOSEPH P
    权利人:UNIV AKRON
    摘要:A novel terminally functional (i.e., telechelic) polymers having a polyisobutylene are described. The end groups are styryl and can be reacted with conventional monomers to form copolymers having unique physical properties. Copolymerizations with N-vinyl-2-pyrrolidone produce amphiphilic polymers which are useful in the areas of medicine and agricultural chemicals.

    专利号:US-6872716-B2
    优先权日:2000-09-11
    标题:Antipsychotic sulfonamide-heterocycles, and methods of use thereof
    发明人:WU XINHE; AQUILA BRIAN M; SHAO LIMING; RADEKE HEIKE; CUNY GREGORY D; HAUSKE JAMES R; XIE ROGER L
    权利人:SEPRACOR INC
    摘要:One aspect of the present invention relates to heterocyclic compounds comprising a sulfonamide moiety. A second aspect of the present invention relates to the use of the heterocyclic compounds comprising a sulfonamide moiety to treat diseases, afflictions or maladies caused at least in part by abnormal activity of one or more GPCRs or ligand-gated ion channels. An additional aspect of the present invention relates to the synthesis of combinatorial libraries of the heterocyclic compounds comprising a sulfonamide moiety, and the screening of those libraries for biological activity, e.g., in animal models of psychosis.

    专利号:WO-2004058727-A1
    优先权日:2002-12-20
    标题 :Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
    发明人:CHEN YUANWEI; O'CONNOR STEPHEN JAMES; GUNN DAVID; NEWCOM JASON; CHEN JIANQING; YI LIN; ZHANG HAI-JUN; HUNYADI LASZLO MATYAS; NATERO REINA
    权利人:BAYER PHARMACEUTICALS CORP; CHEN YUANWEI; O'CONNOR STEPHEN JAMES; GUNN DAVID; NEWCOM JASON; CHEN JIANQING; YI LIN; ZHANG HAI-JUN; HUNYADI LASZLO MATYAS; NATERO REINA
    摘要:This invention relates to substituted 3,5-dihydro-4H-imidazol-4-ones compounds which are useful in the treatment of obesity and obesity-related disorders, and as weight-loss and weight-control agents. The invention also provides methods for synthesis of the compounds, pharmaceutical compositions comprising the compounds, and methods of using such compositions for inducing weight loss and treating obesity and obesity-related disorders.

    专利号:US-2002177721-A1
    优先权日:2000-12-04
    标题 :Methods for the stereoselective synthesis of substituted piperidines

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知